Williams & Novak LLC Has $271,000 Stock Position in TruBridge, Inc. (NASDAQ:TBRG)

Williams & Novak LLC cut its stake in shares of TruBridge, Inc. (NASDAQ:TBRG) by 29.8% in the fourth quarter, Holdings Channel reports. The firm owned 13,720 shares of the company’s stock after selling 5,830 shares during the quarter. Williams & Novak LLC’s holdings in TruBridge were worth $271,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. GAMMA Investing LLC bought a new position in shares of TruBridge during the third quarter worth $26,000. Covestor Ltd bought a new position in TruBridge during the third quarter worth about $28,000. First Horizon Advisors Inc. acquired a new position in TruBridge in the third quarter valued at about $33,000. Point72 DIFC Ltd acquired a new position in TruBridge in the second quarter valued at about $56,000. Finally, FMR LLC bought a new stake in shares of TruBridge in the third quarter worth about $85,000. Institutional investors own 88.64% of the company’s stock.

Analyst Upgrades and Downgrades

TBRG has been the topic of several recent analyst reports. Stephens lifted their price objective on TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a report on Wednesday, November 20th. Barclays upped their price target on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $13.00 price objective on shares of TruBridge in a report on Friday, October 4th.

Insider Transactions at TruBridge

In related news, Director Mark V. Anquillare acquired 2,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were bought at an average price of $16.81 per share, for a total transaction of $42,025.00. Following the purchase, the director now directly owns 17,178 shares in the company, valued at approximately $288,762.18. This trade represents a 17.03 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.60% of the company’s stock.

TruBridge Trading Up 2.7 %

NASDAQ TBRG opened at $23.60 on Wednesday. The stock has a market capitalization of $352.35 million, a price-to-earnings ratio of -5.77, a PEG ratio of 4.41 and a beta of 0.67. TruBridge, Inc. has a 52 week low of $7.55 and a 52 week high of $23.74. The stock’s 50 day moving average price is $19.65 and its two-hundred day moving average price is $14.96. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80.

TruBridge (NASDAQ:TBRG) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of $0.44 by ($0.73). The business had revenue of $83.83 million for the quarter, compared to analyst estimates of $82.30 million. TruBridge had a positive return on equity of 1.78% and a negative net margin of 17.72%. During the same quarter in the previous year, the company posted $0.39 EPS. As a group, analysts anticipate that TruBridge, Inc. will post 0.07 earnings per share for the current fiscal year.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.